Mark Isalan

4.1k citations
82 papers · 3.2k · 1 hit paper · h-index 33

Impact in

    • CRISPR and Genetic Engineering
    • Gene Regulatory Network Analysis
    • Microbial Metabolic Engineering and Bioproduction
    • Genomics and Chromatin Dynamics
    • Protein Structure and Dynamics
    • Genetic Neurodegenerative Diseases

Papers in

    • Gene Regulatory Network Analysis 33
    • CRISPR and Genetic Engineering 19
    • Microbial Metabolic Engineering and Bioproduction 7
    • DNA and Nucleic Acid Chemistry 5
    • RNA Interference and Gene Delivery 4
    • Genetic Neurodegenerative Diseases 11

Mark Isalan

81 papers receiving 3.1k citations

Mark Isalan's Hit Papers

Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings 2022 · 206 citations
2060+1+2Years since publication50100150200

Peers

Mark Isalan
Comparison fields: 5 of 115
  • Molecular Biology 2.2k
  • Cellular and Molecular Neuroscience 276
  • Genetics 484
  • Virology 53
  • Modeling and Simulation 46
Replace Onn Brandman with:
Onn Brandman United States
Alfonso Martínez-Arias United Kingdom
Tian Jin United States
Attila Becskei Switzerland
Anna S. Kashina United States
Jason W. Myers United States
Tamar Hashimshony Israel
Han N. Lim United States
Susan M. Parkhurst United States
Takashi Hiiragi Germany
Mark Isalan relative to Onn Brandman United States Onn Brandman's profile →
Citations per field
00.5×2×2.6×
Onn Brandman · 1×
Citations per year

Countries citing papers authored by Mark Isalan

Since Specialization
Citations

This map shows the geographic impact of Mark Isalan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Isalan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Isalan more than expected).

Fields of papers citing papers by Mark Isalan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Isalan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Isalan. The network helps show where Mark Isalan may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Isalan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Isalan Line = papers co-authored together Mark Isalan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2008250
2
Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings
Hit paper breakdown →
2022206
3 2001168
4 2012165
5 2003132
6 1997119
7 2003109
8 2005103
9 1998102
10 201497
11 200595
12 202395
13 200081
14 201971
15 201870
16 200367
17 201766
18 200060
19 201655
20 201652

About Mark Isalan

Mark Isalan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Genetics, Computer Networks and Communications and Aging, having authored 82 papers that have together received 3.2k indexed citations. Recurring topics across this work include Gene Regulatory Network Analysis (33 papers), CRISPR and Genetic Engineering (19 papers), Genetic Neurodegenerative Diseases (11 papers), Microbial Metabolic Engineering and Bioproduction (7 papers), DNA and Nucleic Acid Chemistry (5 papers), Evolution and Genetic Dynamics (4 papers), Virus-based gene therapy research (4 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Molecular Biology (2.2k citations), Cellular and Molecular Neuroscience (276 citations), Genetics (484 citations), Virology (53 citations) and Modeling and Simulation (46 citations). Mark Isalan has collaborated with scholars based in United Kingdom, Spain and Poland. Frequent co-authors include Yen Choo, Michał Mielcarek, Aaron Klug, Mireia Garriga-Canut, Yolanda Schaerli, Konstantinos Michalodimitrakis, Carmen Agustín‐Pavón, Luis G. Serrano, Luís Serrano and Andreas K. Brödel. Their work appears in journals such as PLoS ONE, Nature Communications, Proceedings of the National Academy of Sciences, Cell Systems and ACS Synthetic Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact